(12-306) Evaluation of Nonformulary Polatuzumab Vedotin Use: Patient Characteristics and Implications for Formulary Management at the Hospital of the University of Pennsylvania
Wednesday, December 10, 2025
2:00 PM - 3:00 PM
Location: Bayside A, Level 1
Residency Program: Hospital of the University of Pennsylvania Residency Program Type: PGY2 (Oncology Pharmacy) Residency Program Location: Pennsylvania